| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On June 24, 2004
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1976N-0052N
|
| OTC Nasal Decongestants
|
|
|
|
|
| 1990V-0284
|
| Laser Light Show (Laser Fantasy Rainbow Projector).
|
|
|
|
|
| 1993P-0295
|
| Allocate reg metered inhaler actuator & spacers to CDER
|
|
|
|
|
| 1995P-0153
|
| Albuterol Inhalation Aerosols (Metered Dose Inhalers)
|
|
|
|
|
| 2001V-0491
|
| SKI Dazzle Laser Show
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| 2003N-0400
|
| Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
|
|
|
|
|
| 2003P-0029
|
| Remove metered-dose inhalers (MDI) containing moiety albuter
|
|
|
|
|
| 2003P-0090
|
| Removing Serzone (nefazodone) from the market Bristol-Myers
|
|
|
|
|
| 2003P-0270
|
| Prohibit False and Misleading Labeling
|
|
|
|
|
| 2003P-0441
|
| ANDA suitability for metoprolol tartrate 12.5 mg tablets
|
|
|
|
|
| 2004D-0193
|
| Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
|
|
|
|
|
| 2004N-0166
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Infant Feeding Practices Study II
|
|
|
|
|
| 2004N-0181
|
| Critical Path Initiative
|
|
|
|
|
| 2004N-0221
|
| Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Section 107(f) b
|
|
|
|
|
| 2004P-0171
|
| Standards for 'Similarity' or 'Sameness' of Biotechnology-Derived Products
|
|
|
|
|
| 2004P-0202
|
| Notify State & Federal regulators of GRAS requirements of milk protein Concentrate
|
|
|
|
|
| 2004V-0053
|
| Laser Light Show
|
|
|
|
|
| 2004V-0211
|
| Variance for Mobolazer ML 10 300
|
|
|
|
|
| 1976N-0052N
|
| OTC Nasal Decongestants
|
|
|
|
|
| SUP
7
|
| Bayer HealthCare, LLC (Bayer)
|
| Vol #:
|
| 77
|
|
|
|
|
| 1990V-0284
|
| Laser Light Show (Laser Fantasy Rainbow Projector).
|
|
|
|
|
| VRA
4
|
| HFZ-300 to Calusa Nature Center & Planetarium, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| 1993P-0295
|
| Allocate reg metered inhaler actuator & spacers to CDER
|
|
|
|
|
| LET
2
|
| HFD-7 to 3M Pharmaceuticals
|
| Vol #:
|
| 1
|
|
|
|
|
| 1995P-0153
|
| Albuterol Inhalation Aerosols (Metered Dose Inhalers)
|
|
|
|
|
| LET
2
|
| HFD-7 to 3M Pharmaceuticals
|
| Vol #:
|
| 2
|
|
|
|
|
| 2001V-0491
|
| SKI Dazzle Laser Show
|
|
|
|
|
| VRA
3
|
| HFZ-300 to Daystar Laser Systems
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| C
26
|
| National Assn of Margarine Manufacturers
|
| Vol #:
|
| 8
|
|
|
|
|
| C
27
|
| Biscuit and Cracker Manufacturers Assn (B&CMA)
|
| Vol #:
|
| 8
|
|
| | | | | | | | |
|
|
|
|
| C
28
|
| National Food Processors Assn (NFPA)
|
| Vol #:
|
| 8
|
|
|
|
|
| C
29
|
| DuPont Agriculture & Nutrition
|
| Vol #:
|
| 8
|
|
|
|
|
| C
30
|
| American Palm Oil Council (APOC)
|
| Vol #:
|
| 8
|
|
|
|
|
| 2003N-0400
|
| Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
|
|
|
|
|
| C 107
|
| D. Nuzzo
|
| Vol #:
|
| 15
|
|
|
|
|
| C 108
|
| J. Fox
|
| Vol #:
|
| 15
|
|
|
|
|
| C 109
|
| L. Porter
|
| Vol #:
|
| 15
|
|
|
|
|
| C 110
|
| D. Santora
|
| Vol #:
|
| 15
|
|
|
|
|
| C 111
|
| M. Fritz
|
| Vol #:
|
| 15
|
|
|
|
|
| C 112
|
| M. Evenson
|
| Vol #:
|
| 15
|
|
|
|
|
| C 113
|
| G. Birk
|
| Vol #:
|
| 15
|
|
|
|
|
| C 114
|
| J. Kempe
|
| Vol #:
|
| 15
|
|
|
|
|
| 2003P-0029
|
| Remove metered-dose inhalers (MDI) containing moiety albuter
|
|
|
|
|
| C 13
|
| K. Milmine
|
| Vol #:
|
| 2
|
|
|
|
|
| C 14
|
| E. Feliciano
|
| Vol #:
|
| 2
|
|
|
|
|
| 2003P-0090
|
| Removing Serzone (nefazodone) from the market Bristol-Myers
|
|
|
|
|
| PDN
1
|
| HFD-1 to Public Citizen Health Reasearch Group
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003P-0270
|
| Prohibit False and Misleading Labeling
|
|
|
|
|
| C 77
|
| M. Sprung
|
| Vol #:
|
| 6
|
|
|
|
|
| 2003P-0441
|
| ANDA suitability for metoprolol tartrate 12.5 mg tablets
|
|
|
|
|
| LET
2
|
| HFD-600 to Nabeal M. Saif, R.Ph.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004D-0193
|
| Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
|
|
|
|
|
| C
1
|
| Musculoskeletal Transplant Foundation (MTF)
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0166
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Infant Feeding Practices Study II
|
|
|
|
|
| C
1
|
| International Formula Council
|
| Vol #:
|
| 1
|
|
|
|
|
| C
2
|
| Wyeth
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0181
|
| Critical Path Initiative
|
|
|
|
|
| C
1
|
| Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0221
|
| Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Section 107(f) b
|
|
|
|
|
| C
6
|
| University of Minnesota
|
| Vol #:
|
| 1
|
|
|
|
|
| C
7
|
| NAtional Assn of Chain Drug Stores
|
| Vol #:
|
| 1
|
|
